Across the Membrane Flashcards

1
Q

In the case of a neurotransmitter, what are the three different processes can occur after the NT is released into the synaptic cleft and binds to a receptor (either pre- or post-synaptic receptor)?

A

Diffusion, Enzyme degradation, Reuptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the neurotransmitter detaches from receptor, drifting out of the synaptic cleft, here it becomes absorbed by glial cells.

A

diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

enzymes break it down. Usually, astrocytes absorb the excess neurotransmitters and pass them on to enzymes or pump them directly into the presynaptic neuron.

A

Enzyme degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

re-absorption of a neurotransmitter into the neuron. Transporters, or membrane transport proteins, pump neurotransmitters from the synaptic cleft back into axon terminals (the presynaptic neuron) where they are stored and reused.

A

reuptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If a drug can initiate a cellular response like that caused by the normal endogenous neurotransmitter it is

A

agonist action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If a drug can initiate a cellular response that is like the normal endogenous NT, but lower amplitude it is

A

partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If a drug can block access to the binding site

A

antagonist action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If a drug can initiate a cellular response opposite to that caused by the normal endogenous neurotransmitter it is

A

inverse agonist action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If the receptor is near the normal endogenous neurotransmitter binding site, and the drug can facilitate the binding of the normal endogenous neurotransmitter to its normal receptor

A

allosteric action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sometimes, the binding of a substance has a helper function. This is called

A

allosteric action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If administration of a drug reduces the effect of the agonist

A

antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

blocks binding, but does not produce an effect on its own

A

antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Some antagonists are competitive

A

more agonist can overcome it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Some antagonists are non-competitive

A

more agonist cannot overcome it and it binds irreversibly to the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name the four sites for drug action

A

Ion Channel Receptors
G-Protein Coupled Receptors
Enzymes
Transporter Proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe how drug effects occur at a neuron level.

A

Effects are caused by an interaction with receptor sites on proteins (on the neuron). Drug binding causes a change in the function of these proteins in a characteristic response.

17
Q

Fast neurotransmitters (milliseconds) that transmit things like vision or hearing

A

ionotropic receptors

18
Q

bind to a receptor to facilitate the action of the neurotransmitter

A

Allosteric agonists

19
Q

G-protein coupled receptors are also called

A

metabotropic receptors

20
Q

The neurotransmitter binds directly to ligand-gated ion channel in the postsynaptic membrane, which closes or opens a channel gate and alters the flow of specific ions into a gated cell.

A

The direct pathway

21
Q

G-protein opens or closes ion channels in one of two ways

A

Directly

Indirectly through secondary messengers (e.g., cAMP)

22
Q

The extracellular signal molecule binds with the G-protein receptor on the cell surface and activates phospholipase C, which is located on the plasma membrane. The lipase hydrolyzes phosphatidylinositol 4,5-bisphosphate into two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds with the IP3 receptor in the membrane of the smooth endoplasmic reticulum and mitochondria to open Ca++ channels. DAG helps activate protein kinase C, which phosphorylates many other proteins, changing their catalytic activities, leading to cellular responses and changes in the ion channel.

A

INDIRECT PHOSPHATIDYLINOSITOL PATHWAY:

23
Q

Adenylyl cyclase is a 12-transmembrane glycoprotein that catalyzes ATP to form cAMP. The cAMP produced is a second messenger in cellular metabolism and is an allosteric activator of protein kinase A. Protein kinase A is an important enzyme in cell metabolism due to its ability to regulate cell metabolism by phosphorylating specific committed enzymes in the metabolic pathway

A

INDIRECT cAMP PATHWAY

24
Q

What breaks down breaks down monoamines?

A

monoamine oxidase

25
Q

What breaks down breaks down acetylcholine?

A

acetylcholinesterase

26
Q

The characteristic of a receptor that describes its exclusivity for a particular substance is called its

A

receptor binding specificity

27
Q

a substance are molecularly identical, but geometrically different

A

isomer

28
Q

substances that are mirror images of each other

A

optical isomer

29
Q

A mix of optical isomers is called

A

enantiomers

30
Q

levo

A

left

31
Q

dextro

A

right

32
Q

sinister

A

left

33
Q

rectus

A

right

34
Q

the immediate response from the binding

A

The acute effect of a drug at its receptor

35
Q

changes in the number of receptors or the change in the sensitivity of existing receptors to binding with the exposed substance

A

chronic effects due to a drug

36
Q

An increase in the number of receptors is called xxxxx and occurs most often in response to a xxxxx

A

upregulation, non-competitive antagonist

37
Q

xxxxxx or a decrease in receptors occurs most often in response to long-term exposure to a

A

Downregulation, agonist

38
Q

, long-term exposure to an agonist can cause the existing receptors to

A

lose sensitivity for the endogenous NT

39
Q

and long-term exposition to an antagonist can cause receptors to

A

become more sensitive to the endogenous NT